14 - Myelodysplastic Syndromes and Acute Leukemias Flashcards

1
Q

myelodysplastic syndrome definition

A

spectrum of clonal myeloid disorders characterized by:
ineffective hematopoiesis
cytopenias
qualitative disorders of blood cells
clonal chromosomal abnormalities
variable tendency to evolve into acute leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common clonal hematologic disorder

A

myelodysplastic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

age/gender more likely to get MDS

A

men, old (increases logarithmically with age)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

typical type of mutation causing MDS

A

chromosomal deletions or additions, often chromosomes 5 or 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

risk factors for MDS

A

radiation
drugs/toxins - benzene, alkylating agents, topoisomerase 2 inhibitorss, smoking, hair dye, pesticides etc
other hematologic disorders - aplastic anemia, PNH, congential neutropenia
genetic disorders - Downs, fanconi, NF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clinical manifestations of MDS

A

anemia sx, thrombocytopenia (bleeding/bruising), leukopenia (infxns), polyarthritis, neuropathy, splenomegaly, acquired alpha thalassemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PBS findings in MDS

A

RBCs - anisocytosis, normo-mildly macrocytic, low retics, Howell Jolly bodies, Cabot rings, basophilic stipling
WBCs - small poorly granulated neutrophils w/ hyper or hypo lobed nuclei
platelets - large and agranular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

isolated del(5q)

A
MDS
primarily in middle aged women
macrocytic anemia and normal/inc platelets
megakaryocytes have hypolobulated nuclei
favorable clinical course
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

supportive care for MDS

A

EPO, G-CSF, GM-CSF, IL-11, transfusions, iron chelation, pyridoxine, folic acid, danazol
immunomodulation - cyclosporine, steroids
AML style chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

5-azacytidine (vidaza) and decitabine (dacogen)

A

vidaza is prodrug version of dacogen
reduces DNA methylation > allows reactivation of silenced tumor suppressors
significant side effects - cytopenias, GI, fever, fatigue, aches/pains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

general characteristics of acute leukemias

A

clonal - originate from transformed hematopoietic stem cell
malignant cells do not differentiate or do so abnormally > accumulate in blood, marrow, tissues
inhibits normal hematopoiesis
fatal if untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

who gets more AML - adults or children

A

adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

risk factors for AML

A

genetic - Downs, klinefelter, fanconi, Bloom’s
prior chemo - alkylating agents and topoisomerase II inhibs
radiation
benzene
myelodysplasia, MPDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

important translocations assoc w/ AML

A

t(8,21) - AML w/ maturation (M2)
t(15,17) - acute promyelocytic leukemia (M3)
inv(16) - acute myelomonocytic leukemia (M4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

t(8,21) is assoc w/

A

AML w/ maturation (M2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

t(15,17) is assoc w/

A

acute promyelocytic leukemia (M3)

17
Q

inv(16) is assoc w/

A

acute myelomonocytic leukemia (M4)

18
Q

clinical presentation of AML

A

cytopenias
hyperleukocytosis (inc risk of CNS involvement)
extramedullary dz (gums in M4/5, chloromas w/ M2, CNS)
coagulopathy

19
Q

gum infiltration can be seen with

20
Q

prognosis (general good/bad/ugly) for AMLs M2, M3, M4

21
Q

M3 AML

A

acute promyelocytic, t(15,17)
seen in younger hispanic pts
risk of DIC relatively high
tx w/ all trans retinoic acid

22
Q

tx of AML

A

induction chemo - anthracycline + cytarabine
consolidation chemo
bone marrow transplant

23
Q

special tx for M3 AML

A

ATRA (all trans retinoic acid) + (chemo OR arsenic)

24
Q

prognosis for AML - remission vs long term cure for adults and children

A

adults - 70% remission, 30% cure

children - 90% remission, 40% cure

25
ALL is more common in kids or adults?
kids
26
risk factors for ALL
in utero events, radiation, SES (higher > higher risk), ethnicity (hispanic)
27
ALL is more often B or T cells?
B
28
presentation of ALL
fatigue, malaise, arthralgia, bone pain, lymphadenopathy, hepatosplenomegaly, fever/infxn, bleeding, CN/neuro abnormalities
29
good prognostic factors for ALL
female, age 3-8, low WBC, Pre-B phenotype, C10, low LDH, hyperdiploid cytogeneitcs
30
tx of ALL
one drug is NEVER enough (most drugs are active against it) tx for at least 18 mo get sanctuary sites (CNS) more risk > more intense tx early response is very important prognostic factor relapse is bad sign induction chemo, consolidation chemo, re-induction, maintenance w/ POMP, BM transplant
31
Burkitt lymphoma assoc genetic mutations
in the c-myc gene - t(2;8) t(8;14) t(8;22)
32
mutations in c-myc gene assoc w/
burkitt lymphoma
33
tumor lysis syndrome and prevention
renal failure due to urate nephropathy and CaPO4 crystals can be prevented w/ hydration, allopurinol, alkalinization, recombinant uricase
34
are CNS findings more common in ALL or AML
ALL